January 12, 2026 • 7:00am EST MindMed Rebrands to Definium Therapeutics, Advancing a Leading Late-Stage Psychiatry Pipeline with Three Phase 3 Readouts Expected in 2026
December 18, 2025 • 7:01am EST MindMed to Present at the 44th Annual J.P. Morgan Healthcare Conference